Luque, Monica
Zhelyazkova, Kristina
Vashishta, Laxmikant
Rai, Masna
Sattar, Abid
Petrovic, Katarina
Bucknall, Richard
Leutz, Steffen
Berti, Fausto https://orcid.org/0000-0002-7684-1792
Clinical trials referenced in this document:
Documents that mention this clinical trial
Efficacy and Safety of Biosimilar AVT05 Versus Reference Product Golimumab in Combination with Methotrexate in Moderate-to-Severe Rheumatoid Arthritis: 52-Week Results of a Randomized, Parallel-Group, Double-Blind Study
https://doi.org/10.1007/s40259-025-00748-8
Funding for this research was provided by:
Alvotech Swiss AG
Article History
Accepted: 7 October 2025
First Online: 3 November 2025
Declarations
:
: Monica Luque, Kristina Zhelyazkova, Laxmikant Vashishta, Masna Rai, Abid Sattar, Richard Bucknall, Steffen Leutz, and Fausto Berti are employees at Alvotech. Katarina Petrovic was an employee of Alvotech at the time of the study.
: The study was conducted in accordance with the Declaration of Helsinki, the International Council for Harmonisation Good Clinical Practice guidelines, and the appropriate regulatory requirements in the countries in which the study was conducted. The protocol, its amendments, and informed consent documentation were reviewed and approved by the institutional review board(s) or independent ethics committee(s) at each study site.
: All participants gave written informed consent to participate in the study prior to undertaking any study-related examination or activity. The informed consent document was approved by each study site’s institutional review board or independent ethics committee.
: Not applicable.
: The datasets generated and/or analyzed during the current study are available from the sponsor on reasonable request.
: Not applicable.
: All authors were involved in the conception and design of the study. KZ and RB were involved in the provision of study materials and patients and acquisition of the data. ML, LV, MR, AB, SL, and FB performed the analysis and/or the interpretation of the data. All authors revised the report critically. All authors approved the final version.